Seroba’s investee company, Quanta Dialysis Technologies Ltd, a medical device company providing innovative haemodialysis solutions fo... Read more

Hamilton, Ontario, September 25, 2017. Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-par... Read more

Galway, Ireland – 12 September 2017.  Clinical trial results for Novate’s SENTRY device have been presented by Principal... Read more

Seroba’s investee company, PQ Bypass, today announced data from a subset analysis of the DETOUR I clinical trial during a late-br... Read more